Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis

mBio

Volumn 4, Issue 4, 2013, Pages

  Bouklas, Tejas ^a   Pechuan, Ximo ^a   Goldman, David L ^a   Edelman, Batya ^a   Bergman, Aviv ^a   Friesa, Bettina C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; HYDROGEN PEROXIDE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CELLULAR STRESS RESPONSE; CHRONIC DISEASE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL CELL; FUNGAL STRAIN; FUNGAL VIRULENCE; HUMAN; IN VIVO STUDY; INTRACELLULAR KILLING; MACROPHAGE; MATHEMATICAL MODEL; MENINGOENCEPHALITIS; NONHUMAN; OXIDATIVE STRESS; PATHOGEN CLEARANCE; PRIORITY JOURNAL; RAT;

EUKARYOTA; FILOBASIDIELLA NEOFORMANS; RATTUS;

EID: 84883430293     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00455-13     Document Type: Article

References (56)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
2. Casadevall A, Spitzer ED, Webb D, Rinaldi MG. 1993. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob. Agents Chemother. 37:1383-1386.
3. Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S. 2006. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/ without fluconazole prophylaxis. J. Med. Assoc. Thai. 89:795-802.
4. Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595-596.
5. Bicanic T, Muzoora C, Brouwer AE, Meintjes G, Longley N, Taseera K, Rebe K, Loyse A, Jarvis J, Bekker LG, Wood R, Limmathurotsakul D, Chierakul W, Stepniewska K, White NJ, Jaffar S, Harrison TS. 2009. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin. Infect. Dis. 49:702-709.
6. Litvintseva AP, Mitchell TG. 2009. Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice. Infect. Immun. 77:3188-3195.
7. Fries BC, Casadevall A. 1998. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J. Infect. Dis. 178: 1761-1766.
8. Price MS, Betancourt-Quiroz M, Price JL, Toffaletti DL, Vora H, Hu G, Kronstad JW, Perfect JR. 2011. Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host. mBio 2(3):e00103-11. doi:10.1128/mBio.00103-11.
9. Rzaieva OM, Varbanets' LD, Hudzenko OV. 2011. Optimization of cultivation conditions of Cryptococcus albidus-producers of alpha-Lrhamnosidase. Mikrobiol. Z. 73:10-16. (In Ukrainian.)
10. McFadden DC, Fries BC, Wang F, Casadevall A. 2007. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot. Cell 6:1464-1473.
11. Alanio A, Desnos-Ollivier M, Dromer F. 2011. Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. mBio 2(4):e00158-11.
12. Steenbergen JN, Shuman HA, Casadevall A. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. U. S. A. 98:15245-15250.
13. Kwon-Chung KJ, Bennett JE. 1978. Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am. J. Epidemiol. 108:337-340.
14. Zaragoza O, Chrisman CJ, Castelli MV, Frases S, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2008. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell. Microbiol. 10:2043-2057.
15. García-Rodas R, Casadevall A, Rodríguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. 2011. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 6:e24485.
16. Litvintseva AP, Kestenbaum L, Vilgalys R, Mitchell TG. 2005. Comparative analysis of environmental and clinical populations of Cryptococcus neoformans. J. Clin. Microbiol. 43:556-564.
17. Fu XH, Meng FL, Hu Y, Zhou JQ. 2008. Candida albicans, a distinctive fungal model for cellular aging study. Aging Cell 7:746-757.
18. Roux AE, Chartrand P, Ferbeyre G, Rokeach LA. 2010. Fission yeast and other yeasts as emergent models to unravel cellular aging in eukaryotes. J. Gerontol. A Biol. Sci. Med. Sci. 65:1-8.
19. Kaeberlein M. 2010. Lessons on longevity from budding yeast. Nature 464:513-519.
20. Jain N, Cook E, Xess I, Hasan F, Fries D, Fries BC. 2009. Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis. Eukaryot. Cell 8:858-866.
21. Goldman DL, Casadevall A, Cho Y, Lee SC. 1996. Cryptococcus neoformans meningitis in the rat. Lab. Invest. 75:759-770.
22. Fries BC, Lee SC, Kennan R, Zhao W, Casadevall A, Goldman DL. 2005. Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect. Immun. 73:1779-1787.
23. Steffen KK, Kennedy BK, Kaeberlein M. 2009. Measuring replicative life span in the budding yeast. J. Vis. Exp. 2009:e1209. doi:10.3791/1209.
24. Nielsen K, Cox GM, Litvintseva AP, Mylonakis E, Malliaris SD, Benjamin DK, Jr, Giles SS, Mitchell TG, Casadevall A, Perfect JR, Heitman J. 2005. Cryptococcus neoformans α strains preferentially disseminate to the central nervous system during coinfection. Infect. Immun. 73: 4922-4933.
25. Goldman DL, Fries BC, Franzot SP, Montella L, Casadevall A. 1998. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc. Natl. Acad. Sci. U. S. A. 95:14967-14972.
26. Fries BC, Goldman DL, Cherniak R, Ju R, Casadevall A. 1999. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect. Immun. 67: 6076-6083.
27. Cox GM, Harrison TS, McDade HC, Taborda CP, Heinrich G, Casadevall A, Perfect JR. 2003. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect. Immun. 71:173-180.
28. Lai CY, Jaruga E, Borghouts C, Jazwinski SM. 2002. A mutation in the ATP2 gene abrogates the age asymmetry between mother and daughter cells of the yeast Saccharomyces cerevisiae. Genetics 162:73-87.
29. Ashrafi K, Sinclair D, Gordon JI, Guarente L. 1999. Passage through stationary phase advances replicative aging in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 96:9100-9105.
30. Jorgensen P, Rupes I, Sharom JR, Schneper L, Broach JR, Tyers M. 2004. A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 18:2491-2505.
31. Qin H, Lu M. 2006. Natural variation in replicative and chronological life spans of Saccharomyces cerevisiae. Exp. Gerontol. 41:448-456.
32. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K. 2010. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog. 6:e1000953.
33. Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2010. Fungal cell gigantism during mammalian infection. PLoS Pathog. 6:e1000945. doi:10.1371/ journal.ppat.1000945.
34. Fröhlich KU, Madeo F. 2001. Apoptosis in yeast: a new model for aging research. Exp. Gerontol. 37:27-31.
35. Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, Teparrakkul P, Loyse A, White NJ, Wood R, Jaffar S, Harrison T. 2009. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 23:701-706.
36. Darras-Joly C, Chevret S, Wolff M, Matheron S, Longuet P, Casalino E, Joly V, Chochillon C, Bédos JP. 1996. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin. Infect. Dis. 23:369-376.
37. Casadevall A, Pirofski LA. 2007. Accidental virulence, cryptic pathogenesis, Martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryot. Cell 6:2169-2174.
38. Kennedy BK, Austriaco NR, Jr, Guarente L. 1994. Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life span. J. Cell Biol. 127:1985-1993.
39. Fries BC, Taborda CP, Serfass E, Casadevall A. 2001. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J. Clin. Invest. 108:1639-1648.
40. Feldmesser M, Kress Y, Casadevall A. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365.
41. Huang YC, Kao HT, Lin TY, Kuo AJ. 2001. Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia. Am. J. Perinatol. 18:141-146.
42. Cruz MC, Goldstein AL, Blankenship J, Del Poeta M, Perfect JR, McCusker JH, Bennani YL, Cardenas ME, Heitman J. 2001. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob. Agents Chemother. 45:3162-3170.
43. Waugh MS, Nichols CB, DeCesare CM, Cox GM, Heitman J, Alspaugh JA. 2002. Ras1 and Ras2 contribute shared and unique roles in physiology and virulence of Cryptococcus neoformans. Microbiology 148:191-201.
44. Ma H, May RC. 2009. Virulence in cryptococcus species. Adv. Appl. Microbiol. 67:131-190.
45. Kronstad J, Saikia S, Nielson ED, Kretschmer M, Jung W, Hu G, Geddes JM, Griffiths EJ, Choi J, Cadieux B, Caza M, Attarian R. 2012. Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot. Cell 11:109-118.
46. Delaney JR, Murakami CJ, Olsen B, Kennedy BK, Kaeberlein M. 2011. Quantitative evidence for early life fitness defects from 32 longevityassociated alleles in yeast. Cell Cycle 10:156-165.
47. Ormerod KL, Morrow CA, Chow EW, Lee IR, Arras SD, Schirra HJ, Cox GM, Fries BC, Fraser JA. 2013. Comparative genomics of serial isolates of Cryptococcus neoformans reveals gene associated with carbon utilization and virulence. G3 3(4):-675-686.
48. Aldridge BB, Fernandez-Suarez M, Heller D, Ambravaneswaran V, Irimia D, Toner M, Fortune SM. 2012. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335:100-104.
49. Collado M, Blasco MA, Serrano M. 2007. Cellular senescence in cancer and aging. Cell 130:223-233.
50. Leslie PH. 1945. On the use of matrices in certain population mathematics. Biometrika 33:183-212.
51. Kwon-Chung KJ, Edman JC, Wickes BL. 1992. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60:602-605.
52. Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, Jain P, Ragan MA, Banerjee U, Fries BC. 2005. Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J. Clin. Microbiol. 43:5733-5742.
53. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
54. Cotter G, Doyle S, Kavanagh K. 2000. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol. Med. Microbiol. 27:163-169.
55. Meyer CD. 2000. Matrix analysis and applied linear algebra. Miscellaneous titles in applied mathematics series. Society for Industrial and Applied Mathematics (SIAM), Philadelphia, PA.
56. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E. 1953. Equations of state calculations by fast computing machines. J. Chem. Phys. 21:1087-1092.